All news

EU R&D keeps active

EU R&D keeps active

There has been 'unprecedented development' in terms of the
Community's research policy in the last year claims the European
Commission's 2002 annual report on technological research and
development (RTD) in 2001.

Biogen digs into Europe

Biogen digs into Europe

Biotechnology company Biogen this week celebrated its 25th
anniversary by breaking the ground on a large-scale manufacturing
facility in Hillerød, Denmark, marking the company's first
development phase for the region and a greater...

Pharma boom for Denmark

Pharma boom for Denmark

Data published by the Danish Association of the Pharmaceutical
Industry (LIF) reveals a boom in pharmaceutical exports in 2002.
Sales totalled DK30.3 billion (€4.3 billion), an increase of
approximately DK2 billion (€268 million)...

RNAi tools

RNAi tools

Dharmacon, a US supplier of RNA and RNA-interference research
products, announced today it has launched Cell Cycle siARRAY, a
collection of ready-to-use siRNA duplexes designed to knock down
112 genes involved in cell cycle regulation.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...